Effective treatment of obesity: ways to fight epidemic of diabetes mellitus

Por A. S. Ametov
Publicado em 2013-12-01

Experience of using Xenical for pilots

Por A S Ametov, A A Belykh
Publicado em 2008-06-01

MODERN POSSIBILITIES OF THERAPY OF TYPE 2 DIABETES MELLITUS PATIENTS. EFFECTIVENESS AND CARDIOSAFETY OF ALOGLIPTIN FROM THE POINT OF VIEW OF EVIDENCE-BASED MEDICINE

Por A. S. Ametov, E. V. Doskina
Publicado em 2017-07-01

Nonglycemic effects of dipeptidyl peptidase-4 inhibitors

Por A S Ametov, L L Kamynina
Publicado em 2013-01-01

New strategies in angioprotective therapy for patients with Type 2 diabetes mellitus and arterial hypertension

Por A. S. Ametov, T. Yu. Demidova, S. A. Kosykh
Publicado em 2005-02-01

New perspectives of renoprotection in patients with Type 2 diabetes mellitus and arterial hypertension

Por A. S. Ametov, T. Yu. Demidova, S. A. Kosykh
Publicado em 2004-12-01

Dipeptidyl peptidase 4 inhibitors in modern domestic practice

Por A. S. Ametov, N. A. Chernikov, O. A. Knyshenko
Publicado em 2020-05-01

The modern paradigm for assessment of the integral parameters аnd the glycemic variability - the role for the type 2 diabetes mellitus management

Por N. A. Chernikova, L. L. Kamynina, A. S. Ametov
Publicado em 2019-08-01

Diabetes and hypertension

Por E. A. Ermakova, A. S. Ametov, N. A. Chernikova
Publicado em 2015-12-01

Dynamics of lipid profile and circadian pressure rhythms in patients with obesity and arterial hypertension, treated with orlistat and its combination with ACE inhibitors

Por A. G. Avtandilov, A. S. Ametov, A. K. Ausheva, A. K. Bolotseva
Publicado em 2005-02-01

Estrogen/androgen balance in men with hyperestrogenism normalized by using letrozole of the aromatase inhibitor drug class

Por Z. Sh. Pavlova, A. S. Ametov, I. I. Golodnikov, A. A. Kamalov
Publicado em 2022-03-01

Current approaches to controlling type 2 diabetes

Por Aleksandr Sergeevich Ametov, Ekaterina Vladimirovna Karpova, Ekaterina Valer'evna Ivanova, A S Ametov, E V Karpova, E V Ivanova
Publicado em 2009-10-01

EXPERT CONSENSUS. ROLE OF COMBINATION LIPID-LOWERING THERAPY (SIMVASTATIN/EZETIMIBE 20/10 MG) IN THE CORRECTION OF LIPID METABOLISM DISTURBANCES IN PATIENTS WITH CHRONIC KIDNEY DIS...

Por A. Catapano, E. V. Shlyakhto, A. I. Martynov, R. G. Oganov, V. V. Kukharchuk, M. V. Shestakova, A. S. Ametov, S. A. Boicov, M. G. Bubnova, S. V. Villevalde, A. S. Galyavich, Yu. A. Karpov, J. D. Kobalava, O. N. Koziolova
Publicado em 2013-08-01

Empagliflozin in patients hospitalized for acute decompensated heart failure: an expert resolution on the discussion of the EMPULSE trial

Por Yu. M. Lopatin, G. P. Arutyunov, A. S. Ametov, F. T. Ageev, M. B. Antsiferov, O. L. Barbarash, S. V. Villevalde, N. G. Vinogradova, G. R. Galstyan, A. S. Galyavich, S. R. Gilyarevsky, M. G. Glezer, I. V. Zhirov, M. V. Ilyin, A. Yu. Lebedeva, S. V. Nedogoda, V. V. Salukhov, E. I. Tarlovskaya, S. N. Tereshchenko, I. V. Fomin, Yu. Sh. Khalimov, D. V. Cherkashin
Publicado em 2022-04-01

Resolution of the online meeting of Russian experts on the EMPEROR-REDUCED trial

Por G. P. Arutyunov, A. G. Arutyunov, E. I. Tarlovskaya, A. S. Ametov, N. G. Vinogradova, A. A. Garganeeva, M. G. Glezer, I. V. Zhirov, M. V. Ilyin, N. A. Koziolova, A. O. Konradi, A. Yu. Lebedeva, Yu. M. Lopatin, S. V. Nedogoda, V. V. Salukhov, M. Yu. Sitnikova, S. N. Tereshchenko, S. N. Tolstov, Yu. Sh. Khalimov, N. R. Khasanov, A. I. Chesnikova, V. Giga, M. Paсker
Publicado em 2020-12-01